Literature DB >> 12756735

Salicylanilides are potent inhibitors of type III secretion in Yersinia.

Anna M Kauppi1, Roland Nordfelth, Ulrik Hägglund, Hans Wolf-Watz, Mikael Elofsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12756735     DOI： 10.1007/0-306-48416-1_17

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  15 in total

1.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

2.  Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli.

Authors:  Annick Gauthier; Marilyn L Robertson; Michael Lowden; J Antonio Ibarra; José Luis Puente; B Brett Finlay
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).

Authors:  John D Williams; Matthew C Torhan; Venugopal R Neelagiri; Carson Brown; Nicholas O Bowlin; Ming Di; Courtney T McCarthy; Daniel Aiello; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem       Date:  2015-01-13       Impact factor: 3.641

Review 4.  Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Authors:  Miles C Duncan; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

5.  The bacterial type III secretion system as a target for developing new antibiotics.

Authors:  Andrew C McShan; Roberto N De Guzman
Journal:  Chem Biol Drug Des       Date:  2015-01       Impact factor: 2.817

6.  Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.

Authors:  Anatoly Slepenkin; Per-Anders Enquist; Ulrik Hägglund; Luis M de la Maza; Mikael Elofsson; Ellena M Peterson
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

7.  Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.

Authors:  Jianfang Li; Chao Lv; Weiyang Sun; Zhenyu Li; Xiaowei Han; Yaoyao Li; Yuemao Shen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

8.  Designed coiled-coil peptides inhibit the type three secretion system of enteropathogenic Escherichia coli.

Authors:  Mariano Larzábal; Elsa C Mercado; Daniel A Vilte; Hector Salazar-González; Angel Cataldi; Fernando Navarro-Garcia
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

9.  An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.

Authors:  Miles C Duncan; Weng Ruh Wong; Allison J Dupzyk; Walter M Bray; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

10.  Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner.

Authors:  Xiaofeng Bao; Asa Gylfe; Gail L Sturdevant; Zheng Gong; Shuang Xu; Harlan D Caldwell; Mikael Elofsson; Huizhou Fan
Journal:  J Bacteriol       Date:  2014-06-09       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.